Mazdutide for type 2 diabetes remission
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new medicine called mazdutide to see if it can help people with type 2 diabetes achieve remission (return to normal blood sugar levels without needing medicine). It's a placebo-controlled study, meaning some participants will get the real drug and others will get a fake one, to compare results. You must be within 5 years of diagnosis and have a BMI over 24.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with type 2 diabetes within the last 5 years
- Age 18 to 70 years
- A body mass index (BMI) of 24 or higher (a measure of body fat based on height and weight)
- Currently treated with diet and exercise alone, or a stable dose of metformin, or a stable dose of an SGLT2 inhibitor (a type of diabetes pill)
- A1c between 6.5% and 9.0% (this is a blood test that shows your average blood sugar over the past 2-3 months)
- Willing to maintain a stable diet and exercise routine during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a drug called dapansutrile can help control blood sugar and reduce inflammation in people with type 2 diabetes. It may also help prevent or manage diabetes-related complications.
This trial tests whether a lifestyle program can help people recently diagnosed with type 2 diabetes achieve remission. It focuses on diet and physical activity, not medications.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
This trial tests whether mazdutide, a new medicine, can improve blood sugar and reduce liver fat in people with type 2 diabetes and moderate-to-severe fatty liver who are already taking semaglutide (a weekly injection). It aims to find a more effective treatment for these combined conditions.
This study tests a new medication, Mazdutide, to see if it can slow or improve memory and thinking problems in people with type 2 diabetes and early-stage cognitive impairment. It may help by targeting blood sugar control and possibly reducing the impact of diabetes on brain function.
This study tests a once-weekly injection called mazdutide to see if it can help people with prediabetes improve their blood sugar and manage weight. The study compares the drug to a placebo (an injection with no active medicine).
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.